The Beneficial Effects of Sitagliptin, a Dipeptedyl Peptidase-4 (DPP-4) Inhibitor on Experimentally Induced Non-Alcoholic Fatty Liver Disease in Rats

AMELIORATIVE EFFECT OF PIOGLITAZONE AND ROUSVASTATIN ON HFD/STZ-INDUCED HEPATIC INJURY IN RATS

Dapagliflozin Ameliorates Glycemic State, Lipid Profile and Renal Functions in Type 2 Diabetic Rats

Aleglitazar treats non-alcoholic steatohepatitis in mice through PPAR dependent pathway

Effectiveness of canagliflozin with atorvastatin on dexamethasone-induced dyslipidemia and hepatic steatosis in albino rats

Protective Effect of Sodium-Glucose Co-Transporter 2 Inhibitor (Dapagliflozin) on Diabetic Retinopathy in Streptozotocin Induced Diabetes in Rats

Cardioprotective effect Linagliptin (DPP-4 Inhibitor) against myocardial infarction induced in rats with metabolic syndrome

Protective effects of Gemfibrozil, Silymarin, and their combination on liver ischemic/reperfusion insult in rats

EMPAGLIFLOZIN MITIGATES ISCHEMIA/REPERFUSION-INDUCED LIVER INJURY IN RATS: MODULATION OF NF-ΚB, SMAD-4, VEGF, AND FIBRINOGEN PROTEIN EXPRESSIONS

Ameliorative effect of sitagliptin and its cardinal mechanisms in methionine induced- hepatotoxicity in rats